Factors associated with progression to critical illness in 28 days among COVID-19 patients: results from a tertiary care hospital in Istanbul, Turkey

Author:

Sili UluhanORCID,Ay PinarORCID,Topuzoglu AhmetORCID,Bilgin HuseyinORCID,Tigen Elif TukenmezORCID,Sengel Buket ErturkORCID,Caglayik Dilek YagciORCID,Balcan BaranORCID,Kocakaya DeryaORCID,Yildizeli Sehnaz OlgunORCID,Gul FethiORCID,Bilgili BelizORCID,Sarinoglu Rabia CanORCID,Yagci Aysegul KarahasanORCID,Durmusoglu Lutfiye MulazimogluORCID,Eryuksel EmelORCID,Odabasi ZekaverORCID,Direskeneli HanerORCID,Karakurt SaitORCID,Cinel IsmailORCID,Korten VolkanORCID

Abstract

ABSTRACTBackgroundCoronavirus disease 2019 (COVID-19) quickly spread worldwide to become a pandemic. This study aimed to define the predictors of critical illness development within 28 days postadmission.MethodsWe conducted a prospective cohort study including 477 PCR-positive COVID-19 patients admitted to a tertiary care hospital in Istanbul from March 12 to May 12, 2020. The development of critical illness, e.g., invasive mechanical ventilation and/or death, was followed for a period of 28 days postadmission. Demographic characteristics, number of comorbidities, illness severity at admission defined by the WHO scale, vital signs, laboratory findings and period of admission to the hospital were independent variables. Cox proportional hazards analysis was performed, and the C-index was calculated.ResultsThe median (IQR) age of the cohort was 55.0 (44.0-67.0) years, and 50.1% were male. The most common presenting symptoms were cough, dyspnea and fatigue. Overall, 65.2% of the patients had at least one comorbidity. Hydroxychloroquine was given to 99.2% of the patients. Critical illness developed in 45 (9.4%; 95% CI: 7.0%-12.4%) patients. In the multivariable analysis, age (HR: 1.05, p<0.001), number of comorbidities (HR: 1.33, p=0.02), procalcitonin ≥0.25 µg/L (HR: 2.12, p=0.03) and LDH ≥350 U/L (HR: 2.04, p=0.03) were independently associated with critical illness development. The WHO scale on admission was the strongest predictor of critical illness (HR: 4.15, p<0.001). Prognosis improved within the study period (p<0.05). The C-index of the model was 0.92.ConclusionsAge, comorbidity number, WHO scale, LDH and procalcitonin were independently associated with critical illness development. Mortality from COVID-19 seems to be decreasing as the pandemic advances.summaryWe analyzed 477 confirmed COVID-19 patients for the development of critical illness, e.g., invasive mechanical ventilation and/or death within 28 days postadmission. Age, comorbidity number, WHO scale, LDH and procalcitonin were independently associated with critical illness development.

Publisher

Cold Spring Harbor Laboratory

Reference28 articles.

1. Republic of Turkey Ministry of Health. COVID-19 Weekly Situation Report 13/07/2020 – 19/07/2020, https://dosyamerkez.saglik.gov.tr/Eklenti/38021,covid-19-weekly-situation-report---29-weekpdf.pdf?0&_tag1=44DBE7E25D380A645A4780C04D8C19C0EF692249 (accessed 17 August 2020).

2. Republic of Turkey Ministry of Health. COVID-19 Rehberi (Guideline), https://covid19bilgi.saglik.gov.tr/tr/covid-19-rehberi.html (accessed 17 August 2020).

3. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

4. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

5. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3